A bill to amend the Federal Food, Drug, and Cosmetic Act to establish a time-limited conditional approval pathway, subject to specific obligations, for certain drugs, and for other purposes.
About This Bill
Committee
Latest Action · December 19, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.